MedTrace Logo

Topical Local Anaesthesia and Cooling During Capsaicin 8% Patch Application

NCT01523951 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2012-03-20

No results posted yet for this study

Summary

Aim of the study is to demonstrate superiority of a continuous cooling of the skin over topical EMLA or placebo in reducing the burning pain during the application of capsaicin 8% patch ("Qutenza").

Secondary it will be tested, if the 2 different pre-treatments have an effect on the application pain within the first 24 hours, and if different pre-treatments have an effect on the reduction of the epidermal nerve fiber density (ENFD) 1 week after Qutenza application.

Conditions

Sponsors & Collaborators

  • Astellas Pharma GmbH

    collaborator INDUSTRY

  • Medical University of Vienna

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01523951 on ClinicalTrials.gov